It is commendable that CureMetrix is the first company to propel women’s healthcare to the heights of artificial intelligence. The company’s policies, products, and AI healthcare innovations aim to improve disease diagnosis detection and enhance cancer surveillance.
Knowing the importance of ensuring thorough examination of mammograms, the company has also rendered AI in women’s healthcare tools that are FDA-approved to assist radiologists in identifying culprits of abnormal mammograms. More impressive about this healthcare technology is its natural advancement and its capability to revolutionize the lives of countless women worldwide.
Kevin Harris called it, the president and co-founder of CureMetrix, said: "AI has been applied on mammograms for a pretty long time. We are the first company in history to get FDA clearance on an AI-based tool for mammography". Receiving this clearance was very important for CureMetrix and placed the company towards the forefront of its area. It also served the company well in promoting its great and effective healthcare technology.
Breast cancer is hard to detect but can potentially be treated if found in time, and this is where research has relied on mammograms to aid in identifying cancer areas within the breast. Nonetheless, imaging is a multi-faceted intervention since radiologists are sifting through multiple images to identify a potential abnormality in the affected breast area.
Harris affirms that “AI can see much detail in the images and can also be utilized effectively when giving assessments to the radiologists.” How AI in women’s healthcare technology can be leveraged to review millions of images simultaneously, highlighting patterns or details that the human eye may miss, addressing the long-standing deficit of radiologists' diagnosis productivity.
Considering only the US population, approximately 330 million people, it is safe to say that CureMetrix’s technology will significantly impact the population. Each year, nearly 40 million mammograms are performed in the country. Predicting trends using big data analytics, the public health sector could see immense health benefits if even a minute fraction of that enhancement in accuracy is achieved.
When combined with innovative smart systems like CureMetrix AI in women’s healthcare tools, these results can improve cancer detection rates significantly. With evidence always emerging on benefits associated with prompt diagnosis, there is great pressure on the need for electronic medical report systems to become a reality, especially when handling breast cancer.
Even though the use of AI in healthcare is developing, CureMetrix is already proving its ability to change how women’s health AI is conceptualized and tackled. In collaborating with medical centres to obtain or incorporate required data, CureMetrix seeks to enhance its AI systems further, making them superior.
The company's technology is already in the market, having acquired FDA approval. This enables the firm to reduce breast cancer deaths and establish a benchmark for future AI healthcare innovations.
The work of Harris and CureMetrix has given hope to millions of women, as the future of women’s health AI appears to be getting better with every passing moment. AI is used to support inspired minds rather than replace them at CureMetrix. And, despite the overwhelming odds against them, the company can optimize procedural time and help preserve lives.